Trending

#drugDev

Latest posts tagged with #drugDev on Bluesky

Latest Top
Trending

Posts tagged #drugDev

Preview
GMP Process Technician (REF0125) | Seda CMS We are currently recruiting for the role of GMP Process Technician in our Seda CMS division.

Opportunity for #GMP Process Technician at Seda Pharmaceutical Development Services (Cheadle, South Manchester UK) ref: REF0125 | closing: 28-Oct-2025 #DrugDev #chemsky πŸ§ͺ
sedacms.com/vacancy/gmp-...

1 0 0 0
Preview
Molecular Modelling Market Share, Trends | Growth Analysis By 2032 Molecular Modelling Market expected to reach 9.1% CAGR growth forecast period 2023-2032, Molecular Modelling Market Categorizes by Product, Application and Region |Molecular Modelling Industry

🧬 Molecule magic! #MolecularModelling accelerates drug discovery & protein engineering πŸ’»πŸ”¬
#ComputationalBiology #PharmaTech #DrugDev

www.marketresearchfuture.com/reports/mole...

2 0 0 0

Chirality matters. Miss it, and drug safety & efficacy suffer. With #HRIM-MS, our customers resolve enantiomers others can’t, saving costs & improving outcomes. We are proud to share what our customers are up to here: view-su2.highspot.com/viewer/766d6....

#Chirality #DrugDev #MassSpec #MOBIE

2 0 0 0

Oligo therapeutics hold promise, but PS modifications create a tangle of stereoisomers that are hard to resolve. Genentech scientists used #SLIM-based #HRIM-MS to finally separate them, enabling smarter design, better control, and safer drugs.

#RNAi #Oligos #MassSpec #DrugDev #CustomerImpact

1 0 0 0
Preview
AI Meets IPF: Taking an AI-Designed Drug from Target Discovery to Phase IIa Results from the GENESIS-IPF Phase IIa trial, now published in Nature Medicine, signal the emergence of artificial intelligence-based tools as a practical, efficient paradigm for drug discovery.

Check out our Behind-The-Paper article talking about the intersection of #aging target research and drug dev to fill a desperate clinical need for patients with no curative therapeutic options:
communities.springernature.com/posts/ai-mee...

#IPF #drugdev #AI #genAI

0 0 0 0

For some context, we have known for >10 yrs that colibactin (the toxin) induces DNA damage/mutations that would likely drive cancer.

Emily Balskus' work, among others, demonstrated this.

But we are unlikely to have a treatment anytime soon. What gives?

#microbiome #drugDev #infectiousDisease

2 1 1 0
Data slide on J&J new drug delivery advice for bladder cancer, which happens to look like a pretzel.

Data slide on J&J new drug delivery advice for bladder cancer, which happens to look like a pretzel.

I know bladder cancer is a serious, terrible disease.

But at the same time this J&J slide popped up and I thought: "Would you like a bladder pretzel?"

#drugDev #pharma #ImSorry

0 0 0 0

#hiring #chemSky #chemistry #drugDev

1 0 0 0

#hiring #chemSky #chemistry #pharma #drugDev

0 0 0 0

Some of our recent work on models to design molecular glues, PROTACs (and really anything that forms a protein-protein complex) -- presented by Aram Davtyan at Keystone on Proximity-based Therapeutics this week!

#targetedDegradation #PROTAC #molecularGlue #drugDev #drugDesign #biotech #bioSky

0 0 0 0
Post image

Aram Davtyan giving an awesome poster presentation about our work modeling protein-small molecule-protein ternary complexes at @keystonesymposia.bsky.social Proximity-Based Therapeutics! #biotech #drugDev #degraders #molecularGlues #PROTACs

Find the poster here: www.deeporigin.com/academic-pos...

3 1 0 1
Preview
Patient Access Tracker | Oribiotech Ltd Updated December 2024 – Ori has calculated the number of patients treated with commercially available cell therapies

For those working in #cellTherapy, Ori Biotech has created tracker of all patients treated with commercially-available cell therapies.

It hovers around 33,000.

#biotech #pharma #drugDev

oribiotech.com/insight/pati...

4 1 0 0
Post image

Something I am always baffled by: Center for Biologics Evaluation and Research (CBER) in the FDA does *NOT* regulate antibody or other protein therapies.

That's done by Center for Drug Evaluation and Research (CDER) - even though they're biologics.

pmc.ncbi.nlm.nih.gov/articles/PMC...

#drugDev

1 0 0 0
Post image

Ned David (founder at Syrrix, Kythera, Achaogen, Unity Bio) on founding biotechs, being a drug hunter, and lessons he's learned:

1) capital excess is death
2) do the experiment that would destroy the idea first
3) do not go public unless you're absolutely ready

#biotech #startup #bioSky #drugDev

2 1 0 0

Hi there, just joined. πŸ‘‹ Feels better here already #MedSky #ScienceSky #drugdev

4 0 1 0

I'm learning some pharmacology, and I don't know if the pharmacologists can be trusted with acronyms.

They have created: PK/PD, PBPK, PBAM, PBBM, QSP, QST...all of which are related but different concepts or frameworks.

Plz folks, no more P's and B's at least.

#pharmacology #bioSky #drugDev

0 0 1 0

We talk a lot about the reasons drug candidates fail, but I feel like we don't talk enough about WHY specific candidates fail.

Things like "lack of efficacy" or "tox" aren't really actionable. Was it binding affinity? Binding to a homolog? Metabolized too fast? A mix?

#BioSky #ChemSky #drugDev

11 3 2 0
Preview
Senior Scientist, Formulation (REF 1024) | Seda Seda Pharmaceutical Development Services (Seda) provides integrated Pharmaceutical Development and Clinical Pharmacology Services to the Biotech sector. Through a combination of laboratory, modelling ...

Opportunity for #formulation scientist at Seda Pharmaceutical Development Services (Manchester UK) ref: REF 1024 | closing 31-Jul-2024 #DrugDev πŸ§ͺ
www.sedapds.com/vacancy/seni...

3 0 0 0